Search research articles
Contact Us
Filters
Showing results (61-70 of 95) with videos related to
Page
of 10
Sort By:
Neuroscience Letters
|
July 17, 1998
Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study
A J Slooter, P de Knijff, A Hofman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 1, 1997
Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels
J A Kuivenhoven, P de Knijff, J M Boer, et al.
Neurology
|
June 1, 1997
Apolipoprotein E gene and sporadic frontal lobe dementia
M Stevens, C M van Duijn, P de Knijff, et al.
American Journal of Medical Genetics
|
January 23, 2002
Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease
A Maat-Kievit, P Helderman-van den Enden, M Losekoot, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
March 22, 2005
Studying the biological and technical sources of variation in telomere length of individual chromosomes
E S D de Pauw, H Roelofs, A Zwinderman, et al.
Journal of Lipid Research
|
February 1, 1992
Immunological discrimination between the human apolipoprotein E2(Arg158----Cys) and E3 isoforms
K Gerritse, P de Knijff, G van Ierssel, et al.
American Journal of Human Genetics
|
March 20, 2001
An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations
M Kayser, M Krawczak, L Excoffier, et al.
The Journal of Clinical Investigation
|
August 1, 1991
Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree
P de Knijff, A M van den Maagdenberg, A F Stalenhoef, et al.
Atherosclerosis
|
July 1, 1990
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia
P De Knijff, A F Stalenhoef, M J Mol, et al.
Circulation
|
June 17, 1997
Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study
J G van der Bom, P de Knijff, F Haverkate, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 95) with videos related to
Sort By:
Page
of 10
Neuroscience Letters
|
July 17, 1998
Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study
A J Slooter, P de Knijff, A Hofman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 1, 1997
Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels
J A Kuivenhoven, P de Knijff, J M Boer, et al.
Neurology
|
June 1, 1997
Apolipoprotein E gene and sporadic frontal lobe dementia
M Stevens, C M van Duijn, P de Knijff, et al.
American Journal of Medical Genetics
|
January 23, 2002
Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease
A Maat-Kievit, P Helderman-van den Enden, M Losekoot, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
March 22, 2005
Studying the biological and technical sources of variation in telomere length of individual chromosomes
E S D de Pauw, H Roelofs, A Zwinderman, et al.
Journal of Lipid Research
|
February 1, 1992
Immunological discrimination between the human apolipoprotein E2(Arg158----Cys) and E3 isoforms
K Gerritse, P de Knijff, G van Ierssel, et al.
American Journal of Human Genetics
|
March 20, 2001
An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations
M Kayser, M Krawczak, L Excoffier, et al.
The Journal of Clinical Investigation
|
August 1, 1991
Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree
P de Knijff, A M van den Maagdenberg, A F Stalenhoef, et al.
Atherosclerosis
|
July 1, 1990
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia
P De Knijff, A F Stalenhoef, M J Mol, et al.
Circulation
|
June 17, 1997
Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study
J G van der Bom, P de Knijff, F Haverkate, et al.
Page
of 10